- Home
- JRS vs FDMT Comparison
JRS vs FDMT Comparison
Compare JRS & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRS
- FDMT
- Stock Information
- Founded
- JRS 2001
- FDMT 2013
- Country
- JRS United States
- FDMT United States
- Employees
- JRS N/A
- FDMT N/A
- Industry
- JRS Finance/Investors Services
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- JRS Finance
- FDMT Health Care
- Exchange
- JRS Nasdaq
- FDMT Nasdaq
- Market Cap
- JRS 227.7M
- FDMT 207.1M
- IPO Year
- JRS N/A
- FDMT 2020
- Fundamental
- Price
- JRS $7.75
- FDMT $4.13
- Analyst Decision
- JRS
- FDMT Buy
- Analyst Count
- JRS 0
- FDMT 10
- Target Price
- JRS N/A
- FDMT $32.33
- AVG Volume (30 Days)
- JRS 86.6K
- FDMT 449.2K
- Earning Date
- JRS 01-01-0001
- FDMT 08-07-2025
- Dividend Yield
- JRS 8.87%
- FDMT N/A
- EPS Growth
- JRS N/A
- FDMT N/A
- EPS
- JRS N/A
- FDMT N/A
- Revenue
- JRS N/A
- FDMT $23,000.00
- Revenue This Year
- JRS N/A
- FDMT $13,048.65
- Revenue Next Year
- JRS N/A
- FDMT N/A
- P/E Ratio
- JRS N/A
- FDMT N/A
- Revenue Growth
- JRS N/A
- FDMT N/A
- 52 Week Low
- JRS $5.95
- FDMT $2.24
- 52 Week High
- JRS $8.00
- FDMT $28.93
- Technical
- Relative Strength Index (RSI)
- JRS 43.25
- FDMT 54.45
- Support Level
- JRS $7.73
- FDMT $4.21
- Resistance Level
- JRS $7.82
- FDMT $4.62
- Average True Range (ATR)
- JRS 0.09
- FDMT 0.30
- MACD
- JRS -0.03
- FDMT -0.02
- Stochastic Oscillator
- JRS 6.25
- FDMT 37.42
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.